We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

4 hedge funds and large institutions have $9K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $8K → $9K (+$1K)

0% more funds holding

Funds holding: 4 → 4 (0)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$7K – – –
ACM
2
Academy Capital Management
Texas
$1K – – –
QCIG
3
Quad-Cities Investment Group
Iowa
$1K – – –

PVCT Hedge Fund Activity: Q3 2019 in Review

4 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q3 2019, worth a combined $9K — up 13% from $8K a quarter earlier.

Fund positioning in PVCT was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $9K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q3 2019, up 13% quarter-over-quarter.
  • 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q3 2019 and 0 closed out.

Based on aggregated 13F filings for Q3 2019.